Teva sticking to strategy as chief departs

5 November 2013 - Deborah Wilkes


Teva Pharmaceutical Industries will continue to build its OTC business following the sudden departure of its president and chief executive officer Dr Jeremy Levin.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: